埃及血液透析患者的 COVID 后焦虑、抑郁和生活质量。
Post-COVID anxiety, depression, and quality of life among Egyptian hemodialysis patients.
机构信息
Nephrology unit, Damietta Specialized Hospital, Damietta, Egypt.
Mansoura Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
出版信息
Ther Apher Dial. 2024 Aug;28(4):608-619. doi: 10.1111/1744-9987.14128. Epub 2024 Apr 17.
INTRODUCTION
This study examined the impact of Coronavirus disease 2019 on anxiety, depression, and health-related quality of life (HRQOL) among Egyptian hemodialysis (HD) patients.
METHODS
This multicenter cross-sectional study was carried out in Egypt in the years 2021-2022, where 300 HD patients from four HD centers were allocated into two groups: post-COVID and non-COVID. The Hospital Anxiety and Depression Scale (HADS) and the Kidney Disease QOL-36 questionnaire were used to assess anxiety, depression, and QOL of the included patients.
RESULTS
In the post-COVID group, abnormal and borderline cases of anxiety and depression were detected in 38.6% and 62.5% of patients, respectively, with no statistically significant difference between both groups. The post-COVID group showed higher work status and lower sexual and physical functioning, which correlated negatively with anxiety and depression scores.
CONCLUSION
Past-COVID infection did not influence depression and anxiety symptoms in HD patients. Sexual and physical functioning were more affected among COVID-survivors.
介绍
本研究考察了 2019 年冠状病毒病（COVID-19）对埃及血液透析（HD）患者焦虑、抑郁和健康相关生活质量（HRQOL）的影响。
方法
本多中心横断面研究于 2021-2022 年在埃及进行，将来自四个 HD 中心的 300 名 HD 患者分为 COVID-19 后组和非 COVID-19 组。采用医院焦虑和抑郁量表（HADS）和肾脏病生活质量-36 问卷评估纳入患者的焦虑、抑郁和 QOL。
结果
在 COVID-19 后组中，分别有 38.6%和 62.5%的患者出现焦虑和抑郁的异常和边缘病例，但两组之间无统计学差异。COVID-19 后组的工作状态较高，性和身体功能较低，与焦虑和抑郁评分呈负相关。
结论
过去的 COVID-19 感染并未影响 HD 患者的抑郁和焦虑症状。COVID-19 幸存者的性和身体功能受到的影响更大。
Zotero 插件